PALEXIA is indicated for the relief of moderate to severe acute pain in children from 2 years of age with a body weight of more than 16 kg and in adults, which can be adequately managed only with opioid analgesics.
PALEXIA SR is indicated for the management of severe chronic pain in adults, which can be adequately managed only with opioid analgesics.
PALEXIA is indicated for the relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics.
The purpose of this study is to evaluate the pharmacokinetic (PK) profile; and safety and tolerability of a single dose...
The purpose of this study is to evaluate the efficacy, safety, and tolerability of orally administered tapentadol extended release (ER)...